Mesoporous silica nanoparticle-based nanomedicine: Preparation, functional modification, and theranostic applications
Source abstract
Abstract
Mesoporous silica nanoparticles (MSNs) have emerged as cornerstone biomaterials for nanomedicine due to their highly tunable physicochemical properties. This review highlights recent breakthroughs in MSN-based platforms for disease theranostics. We systematically outline fundamental synthesis strategies and detail how surface functionalization-imparting properties such as targeting, stimuli-responsiveness, and biomimicry-transforms MSNs from passive carriers into intelligent theranostic agents. The review then summarizes the major contributions of these engineered platforms across key diagnostic ( e.g. , advanced imaging) and therapeutic ( e.g. , targeted drug delivery, dynamic therapies) applications, underscoring their potential in tackling complex diseases. Finally, we address the critical challenges hindering clinical translation, including manufacturing scalability and long-term biocompatibility. We conclude by outlining future directions, such as integration with emerging modalities like immunotherapy, aimed at accelerating the bench-to-bedside transition of MSN-based nanomedicines.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Lipid nanoparticle formulations for optimal RNA-Based topical delivery to murine airways10.1016/j.ejps.2022.106234 ↗
2. Nanomedicine and versatile therapies for cancer treatment, MedComm
3. Inorganic porous nanoparticles for drug delivery in antitumoral therapy10.1002/biot.202000150 ↗
4. Recent progress in targeted delivery vectors based on biomimetic nanoparticles10.1038/s41392-021-00631-2 ↗
5. Extravaganza of nanobiotechnology in the diagnosis and treatment of dementia patients10.2174/1385272827666221027103050 ↗
6. Nanoceria-based lateral flow immunoassay for hydrogen peroxide-free colorimetric biosensing for C-reactive protein10.1007/s00216-022-03877-z ↗
7. Chidamide stacked in magnetic polypyrrole nano-composites counter thermotolerance and metastasis for visualized cancer photothermal therapy10.1080/10717544.2022.2068697 ↗
8. Nanoparticles in the diagnosis and treatment of vascular aging and related diseases10.1038/s41392-022-01082-z ↗
9. Smart cancer nanomedicine for synergetic therapy10.2174/0109298673300897240602130258 ↗
10. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy10.1126/sciadv.abc7031 ↗
11. Obstacles and opportunities in a forward vision for cancer nanomedicine10.1038/s41563-021-01047-7 ↗
12. Delivering the power of nanomedicine to patients today10.1016/j.jconrel.2020.07.007 ↗
13. Toxicological impact of diclofenac sodium: hematological, biochemical and histopathological changes in male rats
14. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
15. Nanocarriers used in drug delivery to enhance immune System in cancer therapy10.3390/pharmaceutics13081167 ↗
16. Doxil®--the first FDA-approved nano-drug: lessons learned10.1016/j.jconrel.2012.03.020 ↗
17. Nanoparticles in the clinic: an update post COVID-19 vaccines10.1002/btm2.10246 ↗
18. Drugs loaded in bilosomes for the treatment of gastrointestinal cancers: a comprehensive review10.62476/abes.101111 ↗
19. Mesoporous silica-based nanoplatforms are Theranostic agents for the treatment of inflammatory disorders10.3390/pharmaceutics15020439 ↗
20. Mesoporous Silica Nanoparticles obtention, functionalization and biomedical applications: a review
21. Near-infrared inorganic nanomaterial-based nanosystems for photothermal therapy10.1039/D1NR00323B ↗
22. 2D MXene nanomaterials for versatile biomedical applications: current trends and future prospects10.1002/smll.202100946 ↗
23. Degradable Holey Palladium Nanosheets with highly active 1D nanoholes for synergetic phototherapy of hypoxic tumors10.1021/jacs.9b12929 ↗
24. Inorganic nanomaterials with intrinsic singlet oxygen generation for photodynamic therapy10.1002/advs.202102587 ↗
25. MOF-Derived nanoparticles with enhanced acoustical performance for efficient mechano-sonodynamic therapy10.1002/adma.202400142 ↗
26. Design and application of inorganic nanoparticles for sonodynamic cancer therapy10.1039/D0BM01875A ↗
27. State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy10.1039/D0TB02360D ↗
28. A metabolic multistage glutathione depletion used for tumor-specific chemodynamic therapy10.1021/acsnano.1c10231 ↗
29. Single-Atom catalysts in catalytic biomedicine10.1002/adma.201905994 ↗
30. Biodegradation-Mediated enzymatic activity-tunable molybdenum oxide nanourchins for tumor-specific Cascade catalytic therapy10.1021/jacs.9b13586 ↗
31. Inorganic nanoparticles in clinical trials and translations10.1016/j.nantod.2020.100972 ↗
32. A comprehensive review on mesoporous Silica nanoparticles: a novel pharmaceutical aid for drug delivery
33. Green synthesis and characterization of silver nanoparticles using Anchusa Officinalis: antimicrobial and cytotoxic potential10.2147/IJN.S511217 ↗
34. Synthesis and antibacterial evaluation of silver-coated magnetic iron Oxide/Activated carbon nanoparticles derived from Hibiscus esculentus10.3390/magnetochemistry11070053 ↗
35. Synthesis and characterization of activated carbon-supported magnetic nanocomposite (MNPs-OLAC) obtained from okra leaves as a nanocarrier for targeted delivery of morin hydrate10.3389/fphar.2024.1482130 ↗
36. Biosafety of mesoporous silica nanoparticles; towards clinical translation10.1016/j.addr.2023.115049 ↗
37. Mesoporous silica nanoparticles as an ideal platform for cancer immunotherapy: recent advances and future directions10.1002/adhm.202400323 ↗
38. Mesoporous silica materials as an emerging tool for cancer immunotherapy10.1002/advs.202200756 ↗
39. Carbon dot-silica nanoparticle composites for ultralong lifetime phosphorescence imaging in tissue and cells at room temperature10.1021/acs.chemmater.9b04120 ↗
40. Multimodal decorations of mesoporous silica nanoparticles for improved cancer therapy10.3390/pharmaceutics12060527 ↗
41. Engineering core-shell mesoporous silica and Fe(3)O(4)@Au nanosystems for targeted cancer therapeutics: a review10.1080/02648725.2022.2147685 ↗
42. Au Nanoparticles@Si Nanowire Oligomer Arrays for SERS: Dimers Are Best10.1021/acsami.4c10004 ↗
43. Magnetic targeting and pH-microwave dual responsive Janus mesoporous silica nanoparticles for drug encapsulation and delivery10.1088/1361-6528/ad42a3 ↗
44. Iron Oxide@Mesoporous Silica Core-Shell nanoparticles as multimodal platforms for magnetic resonance imaging, magnetic hyperthermia, near-infrared light photothermia, and drug delivery10.3390/nano13081342 ↗
45. A review on the recent advancements of polymer-modified mesoporous silica nanoparticles for drug delivery under stimuli-trigger10.3390/polym17121640 ↗
46. Future of mesoporous Silica nanoparticles in nanomedicine: protocol for reproducible synthesis, characterization, lipid coating, and loading of therapeutics (Chemotherapeutic, proteins, siRNA and mRNA)10.1021/acsnano.3c07621 ↗
47. Engineered mesoporous silica-based core-shell nanoarchitectures for synergistic chemo-photodynamic therapies10.3390/ijms231911604 ↗
48. Tuned manganese-impregnated mesoporous silica nanoparticles as a pH-Responsive dual imaging probe10.1021/acsabm.4c01303 ↗
49. Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications
50. In vivo study of light-driven naproxen release from gated mesoporous silica drug delivery system10.1038/s41598-021-99678-y ↗
51. Development of mesoporous silica-based nanoprobes for optical bioimaging applications10.1039/D1BM00204J ↗
52. On the importance of physicochemical parameters of copper and aminosilane functionalized mesoporous silica for hydroxychloroquine release, Materials science & engineering. C10.1016/j.msec.2021.112438 ↗
53. The nanotopography of SiO(2) particles impacts the selectivity and 3D fold of bound allergens10.1039/D1NR05958K ↗
54. Involvement of miR-199a-5p-loaded mesoporous silica nanoparticle-polyethyleneimine-KALA in osteogenic differentiation10.1016/j.jds.2024.01.007 ↗
55. An update on mesoporous silica nanoparticle applications in nanomedicine10.3390/pharmaceutics13071067 ↗
56. Polymeric delivery of therapeutic nucleic acids10.1021/acs.chemrev.0c00997 ↗
57. Multifunctional mesoporous silica nanoparticles for biomedical applications10.1038/s41392-023-01654-7 ↗
58. Recent trends of mesoporous silica-based nanoplatforms for nanodynamic therapies
59. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy10.1016/j.jconrel.2021.10.005 ↗
60. Recent trends of biodegradable mesoporous silica based nanoplatforms for enhanced tumor theranostics10.1016/j.cclet.2024.110221 ↗
61. Smart mesoporous silica nanoparticles in cancer: diagnosis, treatment, immunogenicity, and clinical translation10.1002/smll.202408898 ↗
62. Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics10.1186/s12645-024-00250-w ↗
63. pH-responsive rosuvastatin-loaded nanosystem with superoxide dismutase- and catalase-like properties for M1-to-M2 macrophage repolarization and synergistic anti-atherosclerosis effects
64. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC)10.1016/j.biopha.2019.109561 ↗
65. Recent development of micro-nano carriers for oral antineoplastic drug delivery, Mater
66. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics10.1016/j.biomaterials.2020.120191 ↗
67. Gene regulation technologies for gene and cell therapy10.1016/j.ymthe.2025.04.004 ↗
68. Mesoporous silica nanoparticles for drug delivery10.1002/adfm.201902634 ↗
69. Nanoarchitectured structure and surface biofunctionality of mesoporous Silica nanoparticles10.1002/adma.201907035 ↗
70. Recent applications of mesoporous silica nanoparticles in gene therapy
71. Future of mesoporous Silica nanoparticles in nanomedicine: protocol for reproducible synthesis, characterization, lipid coating, and loading of therapeutics (Chemotherapeutic, proteins, siRNA and mRNA)10.1021/acsnano.3c07621 ↗
72. Dual-driven nanomotors enable tumor penetration and hypoxia alleviation for calcium overload-photo-immunotherapy against colorectal cancer10.1016/j.biomaterials.2023.122332 ↗
73. Precisely targeted nano‐controller of PD‐L1 level for non‐small cell lung cancer spinal metastasis immunotherapy10.1002/adhm.202200938 ↗
74. Mesoporous peroxidase nanozyme for synergistic chemodynamic therapy and chemotherapy10.1016/j.colsurfb.2022.112603 ↗
75. The facile formation of hierarchical mesoporous silica nanocarriers for tumor-selective multimodal theranostics10.1039/D1BM00564B ↗
76. The thermal/pH-sensitive drug delivery system encapsulated by PAA based on hollow hybrid nanospheres with two silicon source10.1080/09205063.2020.1861734 ↗
77. Silver-decorated mesostructured cellular silica foams as excellent antibacterial hemostatic agents for rapid and effective treatment of hemorrhage10.1016/j.msec.2020.111105 ↗
78. Mesoporous silica SBA-15 decreases hyperammonemia and affects the gene expression of mitogen-activated protein kinases in the prefrontal cortex of rats with bile duct ligation, Iran
79. pH-labile artificial natural killer cells for overcoming tumor drug resistance10.1016/j.jconrel.2022.10.042 ↗
80. Supramolecular self‐assembled nanoparticles for targeted therapy of myocardial infarction by enhancing cardiomyocyte mitophagy
81. Euryale ferox seed‐inspired superlubricated nanoparticles for treatment of osteoarthritis10.1002/adfm.201807559 ↗
82. Sol–Gel‐Based advanced porous Silica materials for biomedical applications10.1002/adfm.201909539 ↗
83. Transition-Metal-Based nanozymes: synthesis, mechanisms of therapeutic action, and applications in cancer treatment10.1021/acsnano.4c02265 ↗
84. Sol–gel‐based advanced porous silica materials for biomedical applications10.1002/adfm.201909539 ↗
85. Sol–Gel barium titanate nanohole array as a nonlinear metasurface and a photonic crystal10.1002/smll.202304355 ↗
86. Mesoporous silica nanoparticles as a potential nanoplatform: therapeutic applications and considerations10.3390/ijms24076349 ↗
87. Mesoporous silica nanoparticles‐based nanoplatforms: basic construction, current state, and emerging applications in anticancer therapeutics10.1002/adhm.202201884 ↗
88. Ultrasound‐Propelled nanomotors enable activatable Near‐Infrared‐II Fluorescence imaging‐guided synergistic oxygen‐independent and oxygen‐dependent sonodynamic therapy of atherosclerosis
89. An engineered nanoplatform with tropism toward irradiated glioblastoma augments its radioimmunotherapy efficacy10.1002/adma.202314197 ↗
90. Enantioselective oral absorption of molecular chiral mesoporous silica nanoparticles
91. Nanocrystalline WSe2 excels at high-performance anode for Na storage via a facile one-pot hydrothermal method10.1007/s42864-022-00170-5 ↗
92. Synthesis and mechanism of a new environment-friendly flame retardant (anhydrous magnesium carbonate) by hydrothermal method10.1016/j.apt.2022.103776 ↗
93. Preparation and characterization of Nd-Sb co-doped SnO2 nanoflower electrode by hydrothermal method for the degradation of norfloxacin10.1016/j.cej.2021.129266 ↗
94. Mesoporous silica nanoparticles containing copper or silver synthesized with a new metal source: determination of their structure parameters and cytotoxic and irritating effects10.1016/j.taap.2021.115685 ↗
95. Sustainable synthesis of NaX by quasi-solid phase conversion from coal fly ash10.1016/j.jece.2024.114413 ↗
96. Study on membrane electrolysis for the removal of Fe from the leachate of coal fly ash10.1016/j.jece.2025.117234 ↗
97. Facile hydrothermal assisted basic catalyzed sol gel synthesis for mesoporous Silica Nanoparticle from Alkali Silicate solutions using dual structural templates10.3390/gels10120839 ↗
98. Hantzsch reaction using copper nitrate hydroxide-containing mesoporous silica nanoparticle with C3N4 framework as a novel powerful and reusable catalyst10.1038/s41598-023-36059-7 ↗
99. In situ phagocyte-mediated deep tumor penetration assisted by ApoA-1 mimetic peptide-modified silicasome10.1016/j.nantod.2023.101864 ↗
100. Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer's disease10.1186/s12951-024-02543-z ↗